The poultry vaccines market size is projected to grow from US$ 8.39 billion in 2023 to US$ 12.90 billion by 2031; the market is estimated to record a CAGR of 5.7% during 2021-2031.

The rising prevalence of poultry diseases are the key factors and advancements in vectored and combination vaccines propelling the poultry vaccines market development. However, product recall hamper the poultry vaccines market growth. Furthermore, the advancements in vectored and combination vaccines are likely to remain key poultry vaccines market trends during 2021-2031.

Growth Drivers:

Rising Prevalence of Poultry Diseases Drives Market Growth

Poultry production results in producing different types of animal proteins through eggs and meat. With rising poultry production, there are high chances of susceptibility to several zoonotic diseases such as "Fowl disease" that might result in huge economic losses, particularly in developing countries. For example, chickens are more prone to bacterial, viral, parasitic, and fungal infections. These viral outbreaks can cause Newcastle disease, avian influenza, infectious bursal disease, and other diseases to wide range of poultry animals.

The table below provides disease outbreaks of avian influenza among mammals across several countries in 2022.

Cases of Avian Influenza in Mammals

Country Poultry Diseases Disease Outbreak (2022)

Argentina H5 18

Chile 34

Norway 2

Uruguay 3

Peru 12



Brazil H5N1 5

Canada 40

China 1

Estonia 1

Finland 76

France 2

Ireland 2

Italy 3

Japan 4

Russia 1



Canada H5N5 2



Denmark H5N8 1

Source: World Organization for Animal Health 2023

Poultry diseases are a major cause of death of chicks and also lead to reduced livestock. Farmers are facing huge economic losses worldwide as they spread zoonotic diseases, posing a serious health risk to mammals. For example, poultry coccidiosis is one of the most common diseases across the globe; it leads to huge losses associated with mortality, reduced body weight, and extra expenses related to preventive and therapeutic control. As per the DSM company website, farmers face an economic loss of US$ 3 billion annually owing to coccidiosis in chickens and avian species worldwide. Newcastle disease is also considered an economically expensive disease causing huge production losses to the farmers of developing countries that export poultry products. The International Journal of Current Microbiology and Applied Sciences (IJCMAS) report published in October 2021 reveals that total losses due to Newcastle disease mortality and total expenditure on live birds in all the 25 commercial broiler farms ranged between INR 17,864 (US$ 214.0) to INR 2,66,080 (US$ 3,188.89) and INR 2,78,393 (US$ 3,336.46) to INR 17,86,745 (US$ 21,413.6), respectively. Also, the selling income of live birds from individual farms ranged from INR 1,60,255 (US$ 1,920.61) to INR 12,46,314 (US$ 14,936.7) due to infection.

Therefore, the rising prevalence of poultry diseases resulting in huge economic losses boosts the demand for poultry vaccinations, which drives the market.

Report Segmentation and Scope:

- The poultry vaccines market is segmented into type, technology, dosage form, disease, route of administration, and end user. Based on type, the poultry vaccines market is divided into broiler and layer. The broiler segment held a larger market share in 2023.

- By technology, the market is segmented into live attenuated vaccines, inactivated vaccines, and recombinant vaccines. The live attenuated vaccines segment held the largest market share of the market in 2023.

- In terms of dosage form, the market is categorized into liquid vaccines, freeze-dried vaccines, and dust/powder form vaccines. The liquid vaccines segment dominated the market in 2023.

- In terms of disease, the market is segmented into avian influenza, avian salmonellosis, Marek's disease, infectious bronchitis, infectious bursal disease (IBD), Newcastle disease, and others. The avian influenza segment dominated the market in 2023.

- In terms of route of administration, the market is categorized into drinking water (D/W), intramuscular (I/M), subcutaneous (I/S), and others. The drinking water (D/W) segment dominated the market in 2023.

- In terms of end user, the market is segmented into poultry farms, veterinary hospitals, and poultry vaccination centers & clinics. The poultry farms segment dominated the market in 2023.

Type-Based Insights

By type, the poultry vaccines market is bifurcated into broiler and layer. The broiler segment held the largest market share of the poultry vaccines market in 2023. Broilers are young chickens of six to eight weeks of age with 1.5-2.0 kg average body weight, flexible breastbone cartilage, and pliable and soft meat. They are bred and raised for meat production. The majority of commercial broilers achieve slaughter weight between four and seven weeks of age. Due to intense breeding selection for rapid early growth, broiler breeds are highly vulnerable to skeletal deformity, skin & eye diseases, and congestive heart disorders. To ensure the well-being of the flock, ventilation, housing, stocking density, and in-house operations are examined on a regular basis. As the males grow faster than females, they need higher floor space and nutrients than female broilers. Hence, male and female broiler chicks are reared separately in many countries.

Vaccination programs are one of the essential tools for disease and viral disease prevention, especially for broilers in poultry farming. Vaccines contain the attenuated pathogen or at low concentrations that cause a mild infection or antigenic components of the microorganism, which will make the broiler immune from particular diseases. Vaccines for Marek's disease are given at the hatchery at day one age of broiler by subcutaneous route of administration. Therefore, broiler segment bolster the poultry vaccines market growth during the forecast period.

Regional Analysis:

The geographic scope of the poultry vaccines market report is mainly segmented into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America. Global and regional market analysis covering key market trends, major players, regulations, and recent market developments.

Asia Pacific has dominated the poultry vaccines market and is anticipated to grow with the highest CAGR in the coming years. In Asia Pacific, China accounted for the largest share of the poultry vaccines market in 2023. China is witnessing rapid economic growth and urbanization. China has one of the major healthcare systems in the region. The market growth in the country can be accredited to the growing demand for poultry meat, the increasing consumption of animal-derived food products, the growing livestock population, increasing awareness about animal health, and the rising frequency of poultry disease outbreaks in China. Therefore, favorable government initiatives to promote vaccination among the population of China are the key factor influencing the poultry vaccines market growth.